The 20 Best Primary Progressive Aphasia Doctors Near Me in Ann Arbor, MI

Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as an Advanced provider by MediFind in the treatment of Primary Progressive Aphasia. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).

Judith Heidebrink is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Heidebrink is rated as an Advanced provider by MediFind in the treatment of Primary Progressive Aphasia. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Alzheimer's Disease, Cerebellar Degeneration, Lewy Body Dementia (LBD), and Dementia.

Navid Seraji-Bozorgzad, MD, is an associate professor of neurology in the University of Michigan Medical School.Dr. Seraji-Bozorgzad began work in the area of medical imaging in 1990 as a research assistant during his undergraduate studies at the University of Michigan. He became familiar and developed a fundamental understanding of image acquisition and processing from his work on solid-state imaging arrays. After undergraduate work, he worked in the private sector as a software engineer, designing databases for various companies, including Ford Motor Company, and Liberty Mutual Insurance. The work provided him with experience in data-mining and manipulation of large datasets.His passion for medicine eventually led him to medical school. During the application process he worked in the Department of Psychiatry and Behavioral Neurosciences, and eventually enrolled in graduate school in neuroscience. While in the Department of Psychiatry, he participated in the use of various MR imaging techniques, including magnetic resonance spectroscopy and functional MRI for diagnosis and disease progression in mood disorders, including bipolar disorder. It was during his graduate studies that he developed an interest in the field of neurodegeneration, regeneration and neuroprotection.Dr. Seraji-Bozorgzad's research interest is primarily with non-invasive methods of monitoring disease progression in neurodegenerative disorders, with the ultimate goal of developing a tool set to monitor the efficacy of therapies early on in neurodegenerative disorders.His bibliography includes numerous peer-reviewed jornals and publications, abstracts and other media. Dr. Seraji is rated as an Advanced provider by MediFind in the treatment of Primary Progressive Aphasia. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cerebellar Degeneration, Dementia, Vascular Dementia, and Alzheimer's Disease.

Sami Barmada, M.D., Ph.D. is an assistant professor of neurology at the University of Michigan Medical School. His clinical interests center around patients with dementia and motor neuron disease, and he sees patients at the Cognitive Disorders Clinic in the University of Michigan’s East Ann Arbor location.His research focuses on the pathologic overlap between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), and how we can take advantage of the convergence to identify new and effective therapies for these devastating disorders.After graduating from the University of Pittsburgh, Pennsylvania, in 1998 with a major in Molecular Biology, Biochemistry, and a focus in Conceptual Foundations of Medicine, Dr. Barmada went on to the Medical Scientist Training Program at Washington University in St. Louis School of Medicine. For his graduate work, he constructed a transgenic mouse model of Creutzfeldt-Jacob disease with Dr. David Harris, and used these animals to track the deposition of misfolded prion protein within the nervous system of infected animals. For this work, Dr. Barmada earned earned the Poletsky Award from the Alzheimer’s Disease Research Center in St. Louis, Missouri, and was elected as a Olin Medical Scientist Fellow at Washington University School of Medicine.Dr. Barmada received his M.D. and Ph.D. in 2006, and completed an Internal Medicine internship at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, before moving to the University of California, San Francisco (UCSF), Medical Center for his residency in Neurology. Dr. Barmada served one year as Chief Resident in the Department of Neurology, focusing on resident education. He was also a house-staff nominee to the Alpha-Omega-Alpha honor society. During his residency, Dr. Barmada became involved in research with Dr. Steve Finkbeiner of the Gladstone Institutes, a pioneer in neuronal models of neurodegenerative disease and novel technologies to study these models. Dr. Barmada finished his residency in 2010 and spent one year working with Dr. Finkbeiner as a research fellow, before becoming a Staff Scientist at the Gladstone Institutes and a Clinical Instructor at UCSF. In 2013, Dr. Barmada became an Assistant Professor of Neurology at the University of Michigan, where he divides his time between the Cognitive Disorders Clinic and the laboratory. Dr. Barmada is rated as an Advanced provider by MediFind in the treatment of Primary Progressive Aphasia. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Frontotemporal Dementia, and Dementia. Dr. Barmada is board certified in Neurology.

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as an Advanced provider by MediFind in the treatment of Primary Progressive Aphasia. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.

Dr. MacDonald grew up in St. Ignace, a small town in Michigan’s Upper Peninsula. He attended medical school at Michigan State University’s College of Human Medicine. From there, he completed his neurology residency and then a fellowship in Behavioral Neurology at the Cleveland Clinic.Dr. MacDonald’s primary interests are related to the diagnosis and management of different neurodegenerative diseases of the brain such as Alzheimer’s disease, Lewy body disease, vascular dementia, and frontotemporal dementia. In addition to his clinical activities, Dr. MacDonald has also participated in several clinical trials assessing the safety and efficacy of drugs designed to slow the progression of certain neurodegenerative disorders. Dr. Macdonald is rated as an Advanced provider by MediFind in the treatment of Primary Progressive Aphasia. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Cerebellar Degeneration, Dementia, Charles Bonnet Syndrome, Primary Progressive Aphasia, and Hip Replacement. Dr. Macdonald is board certified in Neurology.

Tanav Popli is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Popli is rated as an Advanced provider by MediFind in the treatment of Primary Progressive Aphasia. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Frontotemporal Dementia, Primary Progressive Aphasia, Neuronal Intranuclear Inclusion Disease (NIID), and Dementia. Dr. Popli is board certified in Neurology.

Nancy Barbas is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Barbas is rated as an Advanced provider by MediFind in the treatment of Primary Progressive Aphasia. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Lewy Body Dementia (LBD), Cerebellar Degeneration, Alzheimer's Disease, and Frontotemporal Dementia.

Benjamin Bly is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Bly is rated as an Experienced provider by MediFind in the treatment of Primary Progressive Aphasia. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Lewy Body Dementia (LBD), Cerebellar Degeneration, Alzheimer's Disease, and Memory Loss.

Dr. Caroline Berglund graduated from Cornell University before obtaining her medical degree at The Ohio State University College of Medicine. She completed her internal medicine training at the University of Michigan. Her clinical interests are in primary care and preventative care. Dr. Berglund is rated as an Experienced provider by MediFind in the treatment of Primary Progressive Aphasia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Spastic Diplegia Infantile Type, Cerebral Palsy, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.

Susan Hickenbottom is a Palliative Medicine provider practicing medicine in Ypsilanti, Michigan. Dr. Hickenbottom is rated as an Experienced provider by MediFind in the treatment of Primary Progressive Aphasia. Her clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Seizures, and Primary Progressive Aphasia.